company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8357000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8357000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2342000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2342000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6015000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2909000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1176000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,620000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,202000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,21000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,176000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,925000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6029000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,570000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-555000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-569000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-74000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-495000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-495000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-495000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1486900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1486900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1500000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2007.0,FY,2007-01-01,2007-12-31,2010-02-25 19:40:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8050000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8050000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2469000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2469000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5581000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2589000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1049000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,543000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2316000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,177000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,78000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,334000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7086000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1505000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,468000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-58000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-526000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2031000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2036000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2036000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2036000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1498500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.36
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1498500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.36
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1497100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,FY,2008-01-01,2008-12-31,2010-02-25 19:40:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.36
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1978000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1978000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,655000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,655000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1323000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,610000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,244000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,131000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,51000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,155000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,20000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,84000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1295000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,112000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-96000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-68000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-62000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1500900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1500900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1550000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 08:52:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2024000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2024000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,604000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,604000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1420000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,655000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,269000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,135000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,48000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1117000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,303000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,118000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-85000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-203000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,100000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,98000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,98000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,98000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1497600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1505200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1400000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2008.0,Q2,2008-04-01,2008-06-30,2009-08-06 16:55:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2079000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2079000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,710000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,710000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1369000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,648000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,261000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,131000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,41000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,18000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1499000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2600000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1231000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,122000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-116000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1347000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-271000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1076000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1076000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1076000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1507900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1507900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1507400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q4,2009-10-01,2009-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8188000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8188000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2576000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2576000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5612000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2635000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1056000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,511000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,191000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,12000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,63000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2038000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6506000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-894000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,407000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-414000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1308000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-283000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1025000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1025000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1025000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1507900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1507900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1507400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 16:40:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2025000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2025000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,629000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,629000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1396000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,665000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,258000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,126000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,51000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,236000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1345000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,51000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,91000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-95000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-44000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,50000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-94000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-94000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-94000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1509300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1509300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1566700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:14:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6109000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6109000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1866000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1866000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4243000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1987000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,795000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,380000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,150000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,45000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,539000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3906000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,337000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,285000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-298000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,39000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-12000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,51000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,51000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,51000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1509300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1509300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1566700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2074000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2074000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,630000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,630000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1444000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,671000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,280000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,126000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,53000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,13000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,16000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1169000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,275000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,92000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-95000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,180000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,158000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,158000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,158000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1506800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1514500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1580000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2,2009-04-01,2009-06-30,2009-08-06 16:55:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4084000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4084000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1237000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1237000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2847000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1322000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,537000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,254000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,99000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,36000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,303000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2561000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,286000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,194000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-203000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,83000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-62000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,145000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,145000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,145000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1506800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1514500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1580000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2010000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2010000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,607000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,607000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1403000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,651000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,257000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,128000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,46000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,23000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,287000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1392000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,102000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-108000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-97000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-84000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1504800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1504800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1300000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2009.0,Q1,2009-01-01,2009-03-31,2010-05-06 16:49:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2002000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2002000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,659000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,659000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1343000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,686000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,224000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,132000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1589000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1877000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,19000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-354000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,995000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,348000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,106000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-118000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,230000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,236000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,236000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,236000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1517800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1517800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1521400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7806000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7806000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2599000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2599000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5207000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2582000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,939000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,513000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,185000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1882000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,116000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-354000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5863000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-656000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,393000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-407000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1063000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1065000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1065000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1065000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1517800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.7
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1517800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.7
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1521400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,FY,2010-01-01,2010-12-31,2013-02-22 16:02:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.7
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1916000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1916000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,623000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,623000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1293000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,634000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,230000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,129000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,39000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1042000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,251000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,91000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-88000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,163000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-27000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,190000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,190000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,190000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1519800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1529300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1461500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 14:14:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5804000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5804000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1940000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1940000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3864000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1896000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,715000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,381000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1774000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,97000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4868000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1004000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,287000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-289000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1293000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1301000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1301000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1301000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1519800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.86
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1529300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.87
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1461500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.86
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7883000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7883000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2650000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2650000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5233000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2544000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,976000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,512000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1815000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,7000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,115000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1499000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7468000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2235000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,409000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-405000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2640000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-263000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2377000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2377000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2377000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1519800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.57
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1529300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.58
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1461500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.57
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1928000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1928000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,654000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,654000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1274000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,634000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,232000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,124000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,26000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,27000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1043000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,231000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,103000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-112000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,119000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,21000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,98000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,98000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,98000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1516600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1525300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1633300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2,2010-04-01,2010-06-30,2010-08-05 14:54:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3888000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3888000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1317000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1317000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2571000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1262000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,485000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,252000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1735000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,92000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3826000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1255000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,196000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-201000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1456000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1491000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1491000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1491000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1516600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.99
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1525300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.99
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1633300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.99
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7992000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7992000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2656000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2656000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5336000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2575000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1004000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,509000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1827000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,119000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1735000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7771000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2435000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,409000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-412000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2847000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-186000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2661000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2661000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2661000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1516600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.76
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1525300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.76
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1633300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.76
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1960000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1960000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,663000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,663000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1297000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,628000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,253000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,128000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1709000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,65000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2783000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1486000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,93000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-89000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1575000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1589000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1589000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1589000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1514500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.05
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1514500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.05
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1513300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1,2010-01-01,2010-03-31,2010-05-06 16:49:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.05
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8138000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8138000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2632000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2632000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5506000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2612000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1052000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,511000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1854000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,12000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,105000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1751000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7897000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2391000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,398000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-395000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2786000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-185000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2601000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2601000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2601000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1514500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.72
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1514500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.72
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1513300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.72
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1848000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1848000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,660000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,660000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1188000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,614000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,231000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,96000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,787000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-722000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1017000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,171000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,71000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-71000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,100000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-7000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,107000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,107000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,107000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1509300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1519000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1520700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7622000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7622000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2659000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2659000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4963000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2494000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,895000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,421000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,172000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,718000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,89000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-730000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4059000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,904000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,281000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,19000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-262000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,642000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,201000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,441000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,441000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,441000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1509300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.29
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1519000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1520700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,FY,2011-01-01,2011-12-31,2014-02-26 16:47:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.29
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1874000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1874000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,680000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,680000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1194000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,635000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,229000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,97000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,36000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,9000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,22000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-8000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1020000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,174000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,62000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-63000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,111000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-31000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,142000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,142000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,142000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1514400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1524000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1577800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3,2011-07-01,2011-09-30,2011-11-08 16:50:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5774000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5774000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1999000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1999000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3775000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1880000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,664000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,325000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-615000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,718000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,78000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-8000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3042000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,733000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,210000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,19000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-191000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,542000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,208000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,334000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,334000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,334000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1514400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1524000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.22
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1577800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7776000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7776000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2658000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2658000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5118000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2566000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,888000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,457000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2204000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2595000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,97000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-362000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4037000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1081000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,316000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-309000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,772000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,202000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,570000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,570000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,570000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1514400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1524000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.39
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1577800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1975000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1975000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,688000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,688000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1287000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,649000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,223000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,96000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,52000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,12000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,18000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1050000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,237000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,73000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-79000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,158000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,146000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,146000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,146000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1528600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1535800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1460000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2,2011-04-01,2011-06-30,2011-08-05 13:29:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3900000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3900000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1319000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1319000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2581000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1245000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,435000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,228000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-651000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,709000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,56000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2022000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,559000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,148000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,20000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-128000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,431000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,239000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,192000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,192000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,192000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1528600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1535800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1460000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7818000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7818000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2601000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2601000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5217000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2565000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,889000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,489000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2201000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2591000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,80000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-354000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4059000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1158000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,345000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-334000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,824000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,206000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,618000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,618000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,618000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1528600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1535800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.42
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1460000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1925000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1925000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,631000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,631000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1294000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,596000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,212000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,132000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-703000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,697000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,38000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,972000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,322000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,75000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,26000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-49000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,273000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,227000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,46000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,46000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1526500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1536300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1533300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1,2011-01-01,2011-03-31,2011-05-05 16:11:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7771000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7771000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2567000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2567000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5204000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2550000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,898000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,517000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2227000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2579000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,89000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-354000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4052000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1152000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,375000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-367000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,785000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,215000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,570000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,570000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,570000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1526500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1536300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1533300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1820000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1820000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,582000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,582000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1238000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,642000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,238000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,100000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,28000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,44000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,69000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1121000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,117000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,63000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-66000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,51000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,61000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,61000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1406700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1406700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1407600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7249000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7249000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2349000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2349000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4900000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2529000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,886000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,395000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,153000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,4492000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,136000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,177000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8768000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3868000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,261000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,22000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-239000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4107000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-39000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4068000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4068000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4068000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1406700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.89
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1406700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.89
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1407600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:11:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.89
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1735000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1735000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,558000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,558000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1177000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,569000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,220000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,99000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,29000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,761000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,54000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,39000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1771000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-594000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,65000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-69000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-663000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-664000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-664000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-664000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1392500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1392500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1383300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3,2012-07-01,2012-09-30,2012-11-06 17:09:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5429000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5429000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1767000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1767000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3662000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1887000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,648000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,295000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,125000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,4492000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,92000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,108000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7647000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3985000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,198000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,25000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-173000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4158000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-29000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4129000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4129000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4129000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1392500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.91
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1392500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.91
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1383300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.91
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7277000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7277000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2427000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2427000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4850000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2501000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,879000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,391000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,912000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,4492000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,103000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-614000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8664000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3814000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,269000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,25000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-244000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4058000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-36000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4022000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4022000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4022000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1392500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.84
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1392500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.84
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1383300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.84
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1828000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1828000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,578000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,578000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1250000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,649000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,213000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,99000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,48000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3731000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,28000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,69000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4837000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3587000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,64000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,33000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-31000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3618000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-40000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3578000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3578000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3578000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1423200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.51
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1423200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.51
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1425500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 17:31:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.51
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3694000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3694000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1209000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1209000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2485000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1318000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,428000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,196000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,96000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3731000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,38000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,69000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5876000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3391000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,133000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,29000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-104000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3495000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-30000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3465000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3465000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3465000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1423200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.43
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1423200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.43
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1425500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.43
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7416000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7416000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2549000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2549000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4867000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2567000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,888000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,389000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,919000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3740000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,71000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-661000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7913000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3046000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,266000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,28000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-238000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3284000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-68000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3216000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3216000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3216000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1423200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.27
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1423200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.27
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1425500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.27
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7563000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7563000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2659000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2659000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4904000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2567000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,898000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,386000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,923000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,21000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,61000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-730000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4126000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,778000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,275000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-286000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,492000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-16000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,508000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,508000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,508000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1445200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1454100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1412500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1866000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1866000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,631000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,631000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1235000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,669000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,215000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,97000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,48000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1039000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,196000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,69000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-73000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,123000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,113000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,113000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,113000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1445200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1454100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1412500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:01:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1838000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1838000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,556000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,556000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1282000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,746000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,217000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,105000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,24000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,46000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,17000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1155000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,127000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,57000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-68000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,59000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-49000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,108000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,108000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,108000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1341200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1341200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1344400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7143000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7143000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2174000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2174000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4969000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2678000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,861000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,410000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,140000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,476000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,101000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,183000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4849000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,120000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,324000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-19000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-343000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-223000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-102000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-121000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-121000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-121000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1341200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1341200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1344400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,FY,2013-01-01,2013-12-31,2015-02-25 16:11:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1735000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1735000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,510000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,510000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1225000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,681000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,217000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,101000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,28000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,19000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,76000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1122000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,103000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,137000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-143000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-35000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1340300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1340300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:40:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5305000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5305000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1618000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1618000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3687000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1932000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,644000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,305000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,116000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,476000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,55000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,166000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3694000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,267000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-275000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-282000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-53000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-229000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-229000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-229000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1340300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1340300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7125000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7125000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2200000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2200000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4925000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2574000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,882000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,405000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,144000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,476000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,99000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,235000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4815000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,110000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,330000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-341000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-231000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-63000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-168000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-168000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-168000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1340300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1340300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1809000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1809000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,530000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,530000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1279000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,643000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,223000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,101000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,47000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,53000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,26000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-34000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1059000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,220000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,65000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-68000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,152000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,130000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,130000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,130000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1343500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1358600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1300000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2,2013-04-01,2013-06-30,2013-08-07 08:22:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3570000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3570000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1108000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1108000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2462000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1251000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,427000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,204000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,88000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,476000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,36000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,90000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2572000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-110000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,130000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-132000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-242000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-18000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-224000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-224000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-224000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1343500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1358600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1300000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7125000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7125000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2248000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2248000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4877000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2462000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,885000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,403000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,145000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1237000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,134000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,198000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5464000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-587000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,258000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-267000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-854000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-27000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-827000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-827000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-827000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1343500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.62
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1358600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.62
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1300000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.62
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7144000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7144000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2296000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2296000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4848000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2468000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,875000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,401000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,146000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,4915000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,136000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,301000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9242000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4394000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,257000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,27000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-230000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4624000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-89000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4535000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4535000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4535000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1351900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.23
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1351900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.23
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1361500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.23
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1761000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1761000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,578000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,578000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1183000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,608000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,204000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,103000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,41000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,423000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,124000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1513000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-330000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,65000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-64000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-394000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-40000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-354000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-354000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-354000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1351900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1351900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1361500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:22:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7380000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7380000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2210000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2210000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5170000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2902000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,817000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,438000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,111000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,195000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,69000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,939000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5471000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-301000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,216000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-208000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-509000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-390000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-119000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-119000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-119000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1324300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1324300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1322200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 16:07:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1887000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1887000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,560000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,560000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1327000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,774000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,208000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,111000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,25000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,18000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,32000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,652000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1820000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-493000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,55000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-61000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-554000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-255000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-299000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-299000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-299000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1324300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1324300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1322200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1846000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1846000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,550000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,550000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1296000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,741000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,212000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,109000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,21000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,12000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,135000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1232000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,64000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,54000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-61000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-40000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,43000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1325500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1347600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1433300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:25:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5493000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5493000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1650000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1650000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3843000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2128000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,609000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,327000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,86000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,177000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,37000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,287000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3651000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,192000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,161000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-147000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,45000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-135000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,180000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,180000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,180000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1325500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1347600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1433300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7331000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7331000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2206000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2206000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5125000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2874000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,826000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,432000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,110000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,177000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,83000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,304000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4806000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,319000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,218000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-215000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,104000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-184000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,288000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,288000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,288000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1325500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1347600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1433300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3647000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3647000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1100000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1100000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2547000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1387000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,397000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,218000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,65000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,165000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,35000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,152000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2419000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,128000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,107000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,21000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-86000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,42000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-95000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,137000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,137000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,137000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1323200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1345000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7220000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7220000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2166000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2166000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5054000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2814000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,831000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,424000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,117000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,165000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,100000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,245000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4696000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,358000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,301000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-297000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,61000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-179000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,240000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,240000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,240000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1323200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1345000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1873000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1873000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,563000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,563000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1310000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,743000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,206000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,109000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,25000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,110000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,15000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,171000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1379000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-69000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,53000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-104000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-108000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1323200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1345000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:05:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1774000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1774000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,537000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,537000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1237000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,644000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,191000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,109000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,40000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,55000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,20000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-19000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1040000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,197000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,54000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-51000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,146000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,133000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,133000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,133000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1321700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1349200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1330000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 16:22:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7156000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7156000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2133000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2133000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5023000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2714000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,848000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,416000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,139000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,108000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,111000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,40000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4376000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,647000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,313000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-330000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,317000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-49000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,366000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,366000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,366000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1321700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.27
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1349200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1330000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.27
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7477000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7477000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2173000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2173000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5304000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2873000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,876000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,495000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,70000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,19000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,26000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1228000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5587000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-283000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,284000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-83000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-367000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-650000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-411000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-239000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-239000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-239000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1341200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1341200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1327800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 06:20:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1978000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1978000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,574000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,574000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1404000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,776000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,243000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,135000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-26000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,493000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1631000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-227000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,60000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-50000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-110000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-337000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-195000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-142000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-142000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-142000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1341200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1341200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1327800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1888000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1888000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,539000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,539000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1349000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,729000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,221000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,131000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,53000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,7000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,497000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1648000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-299000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,58000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-68000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-367000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-169000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-198000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-198000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-198000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1344000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1344000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1320000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:10:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5499000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5499000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1599000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1599000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3900000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2097000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,633000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,360000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,96000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,19000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,16000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,735000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3956000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-56000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,224000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-33000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-257000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-313000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-216000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-97000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-97000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-97000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1344000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1344000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1320000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7386000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7386000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2159000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2159000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5227000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2871000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,841000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,471000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,121000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,37000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,48000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1387000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5776000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-549000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,279000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-39000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-318000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-867000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-471000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-396000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-396000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-396000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1344000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1344000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1320000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1843000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1843000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,540000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,540000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1303000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,700000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,220000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,116000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,9000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,18000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1084000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,219000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,106000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-114000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,105000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,102000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,102000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,102000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1341300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1361800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1275000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:12:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3611000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3611000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1060000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1060000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2551000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1368000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,412000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,229000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,43000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,9000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,238000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2308000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,243000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,166000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-189000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,54000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-47000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,101000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,101000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,101000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1341300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1361800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1275000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7344000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7344000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2170000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2170000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5174000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2883000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,832000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,449000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,89000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,39000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,43000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1025000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5360000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-186000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,275000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-36000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-311000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-497000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-342000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-155000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-155000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-155000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1341300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1361800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1275000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1768000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1768000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,520000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,520000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1248000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,668000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,192000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,113000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,25000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,220000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1224000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,24000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,60000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-75000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-51000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-50000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1333700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1333700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:08:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7374000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7374000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2193000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2193000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5181000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2926000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,818000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,442000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,96000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,140000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,55000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1178000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5655000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-474000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,222000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-232000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-706000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-453000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-253000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-253000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-253000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1333700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1333700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8386000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8386000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2424000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2424000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5962000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3099000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,920000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,545000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,79000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,28000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,833000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5515000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,447000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,233000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-37000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-270000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,177000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-170000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,347000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,347000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,347000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1357600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1377200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1334600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 17:21:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2191000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2191000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,618000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,618000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1573000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,832000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,256000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,138000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,20000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,177000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1433000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,140000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,57000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-51000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,89000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-35000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,124000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,124000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,124000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1357600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1377200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1334600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2105000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2105000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,594000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,594000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1511000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,772000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,232000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,136000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,20000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,7000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-9000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1163000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,348000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,58000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-33000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-91000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,257000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,228000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,228000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,228000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1360600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1379700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1341200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:50:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6195000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6195000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1806000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1806000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4389000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2267000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,664000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,407000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,59000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,7000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,22000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,656000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4082000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,307000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,176000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-43000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-219000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,88000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-135000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,223000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,223000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,223000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1360600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1379700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1341200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8173000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8173000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2380000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2380000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5793000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3043000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,907000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,542000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,33000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,7000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,32000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1149000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5713000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,80000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,236000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-93000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-329000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-249000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-330000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,81000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,81000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,81000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1360600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1379700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1341200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2126000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2126000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,639000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,639000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1487000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,779000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,222000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,135000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,20000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,14000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,651000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1821000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-334000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,59000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-63000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-397000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-190000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-207000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-207000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-207000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1357400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1357400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1380000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:24:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4090000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4090000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1212000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1212000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2878000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1495000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,432000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,271000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,39000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,17000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,665000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2919000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,118000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-128000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-169000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-164000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1357400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1357400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1380000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7956000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7956000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2325000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2325000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5631000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3000000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,896000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,537000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,66000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,34000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1655000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6198000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-567000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,236000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-70000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-306000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-873000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-528000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-345000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-345000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-345000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1357400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1357400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1380000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1964000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1964000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,573000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,573000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1391000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,716000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,210000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,136000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,19000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,14000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1098000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,293000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,59000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-65000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,228000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,202000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,202000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,202000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1350400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1369900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1346700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:26:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7673000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7673000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2226000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2226000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5447000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2921000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,894000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,518000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,64000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,19000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,23000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1022000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5461000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,283000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-74000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-357000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-371000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-335000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1350400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1369900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1346700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9048000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9048000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2593000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2593000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6455000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3294000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,997000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,565000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,68000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,37000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,205000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5170000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1285000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,229000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-124000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-353000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,933000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,828000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,105000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,104000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,104000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1370100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1392700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1300000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,FY,2017-01-01,2017-12-31,2020-02-25 16:58:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2409000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2409000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,674000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,674000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1735000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,885000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,264000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,141000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,20000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,87000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1416000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,319000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,57000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-92000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,228000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,842000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-614000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-615000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-615000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1370100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1392700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1300000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2222000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2222000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,637000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,637000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1585000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,800000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,254000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,139000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,16000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,12000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-16000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1208000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,377000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,57000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-68000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,309000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,283000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,283000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,283000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1372000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1394100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1347600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3,2017-07-01,2017-09-30,2018-10-29 16:50:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6639000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6639000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1919000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1919000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4720000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2409000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,733000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,424000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,50000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,17000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,118000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3754000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,966000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,172000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-89000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-261000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,705000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-14000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,719000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,719000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,719000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1372000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1394100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1347600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8830000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8830000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2537000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2537000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6293000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3241000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,989000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,562000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,70000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,7000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,23000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,295000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5187000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1106000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,229000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-83000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-312000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,794000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-49000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,843000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,843000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,843000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1372000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.62
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1394100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.6
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1347600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.62
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2257000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2257000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,632000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,632000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1625000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,815000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,244000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,142000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,17000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,181000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1400000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,225000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,58000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-76000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-134000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,91000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-55000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,146000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,146000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,146000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1369800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1391100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1327300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:18:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4417000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4417000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1282000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1282000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3135000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1609000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,479000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,285000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,34000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,134000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2546000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,589000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,115000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-78000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-193000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,396000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-40000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,436000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,436000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,436000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1369800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1391100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.32
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1327300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8713000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8713000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2494000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2494000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6219000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3213000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,967000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,559000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,74000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,16000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,302000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5142000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1077000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,230000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-105000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-335000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,742000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-46000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,788000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,788000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,788000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1369800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.58
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1391100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1327300000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.58
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2160000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2160000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,650000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,650000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1510000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,794000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,235000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,143000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,17000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-47000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1146000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,364000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,57000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-59000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,305000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,290000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,290000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,290000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1365400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1390200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1381000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 06:32:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8582000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8582000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2501000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2501000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6081000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3177000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,945000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,552000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,77000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,29000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,772000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5563000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,518000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,231000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-33000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-264000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,254000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-181000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,435000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,435000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,435000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1365400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1390200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1381000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9823000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9823000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2813000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2813000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7011000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3569000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1113000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,599000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,70000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,35000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,36000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,82000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5504000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1506000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,241000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,157000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-84000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1422000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-249000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1671000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1671000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1671000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1381000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.21
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1401400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.19
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1381000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,FY,2018-01-01,2018-12-31,2020-02-25 16:58:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.21
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2561000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2561000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,730000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,730000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1833000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,953000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,288000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,163000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,15000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,76000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1513000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,319000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,65000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,42000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,296000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-90000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,386000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,386000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,386000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1381000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1401400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1381000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2393000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2393000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,672000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,672000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1720000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,870000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,289000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,148000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,17000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1332000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,388000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,58000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,126000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,68000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,456000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,432000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,432000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,432000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1382800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1403900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1393500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 06:33:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7262000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7262000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2083000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2083000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5178000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2616000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,825000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,436000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,52000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,35000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,21000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3991000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1187000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,176000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,115000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-61000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1126000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-159000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1285000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1285000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1285000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1382800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.93
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1403900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.92
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1393500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.93
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9671000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9671000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2757000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2757000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6913000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3501000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1089000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,577000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,70000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,36000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,41000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,93000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5407000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1506000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,233000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,80000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-153000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1354000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,683000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,671000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,670000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,670000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1382800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.48
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1403900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1393500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.48
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2490000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2490000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,739000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,739000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1751000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,886000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,275000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,147000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,17000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,34000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-4000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1360000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,392000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,57000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-45000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,347000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-209000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,556000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,555000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,555000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1380500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1398900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1387500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 16:11:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4869000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4869000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1411000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1411000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3458000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1746000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,536000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,288000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,35000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,35000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,18000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2659000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,799000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,118000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-129000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,670000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-183000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,853000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,853000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,853000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1380500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.62
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1398900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1387500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.62
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9500000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9500000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2722000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2722000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6778000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3431000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1054000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,568000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,69000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,39000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,50000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,72000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5283000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1495000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,232000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-57000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-289000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1207000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,685000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,522000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,521000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,521000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1380500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1398900000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1387500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2379000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2379000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,672000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,672000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1707000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,860000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,261000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,141000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,13000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1299000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,407000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,61000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-84000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,323000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,297000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,298000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,298000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1376500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1396800000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1354500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:23:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10736000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10736000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3116000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3116000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7620000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3941000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1174000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,699000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,65000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,105000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,38000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,80000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6102000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1518000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,473000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-358000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-831000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,687000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4013000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4700000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4700000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4700000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1391500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.38
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1410600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.33
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1390500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,FY,2019-01-01,2019-12-31,2020-02-25 16:58:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.38
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2905000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2905000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,851000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,851000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2054000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1092000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,308000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,200000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,17000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,28000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,198000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1844000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,210000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,180000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-36000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-216000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4002000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3996000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3996000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3996000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1391500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.87
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1410600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.83
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1390500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.87
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7831000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7831000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2265000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2265000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5566000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2849000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,866000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,499000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,48000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,104000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-118000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4258000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1308000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,293000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-322000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-615000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,693000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,704000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,704000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,704000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1393100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1412200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.5
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1400000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10392000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10392000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2995000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2995000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7399000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3802000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1154000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,662000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,66000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,104000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,25000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-42000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5771000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1627000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,358000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-280000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-638000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,989000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-101000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1090000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1090000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1090000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1393100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.79
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1412200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.77
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1400000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.79
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2707000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2707000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,777000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,777000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1930000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1012000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,306000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,178000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,15000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,33000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1547000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,383000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,95000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-197000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-292000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,91000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-35000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,126000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,126000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,126000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1393100000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1412200000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1400000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 06:33:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5124000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5124000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1488000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1488000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3636000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1837000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,560000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,321000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,33000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,104000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,7000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-151000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2711000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,925000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,198000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-125000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-323000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,602000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,578000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,578000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,578000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1391000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1408600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1400000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10078000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10078000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2890000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2890000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7189000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3660000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1137000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,632000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,68000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,104000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,25000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-70000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5556000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1632000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,321000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,43000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-278000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1354000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-42000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1396000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1396000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1396000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1391000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.01
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1408600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.99
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1400000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.01
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2631000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2631000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,758000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,758000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1873000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,968000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,280000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,161000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,17000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,37000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,25000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1489000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,384000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,89000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-150000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-239000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,145000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,154000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,154000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,154000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1391000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1408600000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1400000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 16:11:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2493000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2493000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,730000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,730000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1763000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,869000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,280000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,160000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,16000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,67000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,6000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-176000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1222000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,541000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,109000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,25000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-84000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,457000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,33000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,424000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,424000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,424000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1387700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1408400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1367700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:20:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9937000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9937000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2871000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2871000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7067000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3578000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1132000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,618000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,68000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,101000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,29000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-99000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5427000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1640000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,289000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,205000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-84000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1556000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-242000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1798000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1797000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1797000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1387700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.3
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1408400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.28
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1367700000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.3
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10786000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10786000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3192000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3192000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7594000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4050000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1194000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,740000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,61000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,236000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,42000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,148000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6471000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1123000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,452000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-419000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-871000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,252000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4034000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4286000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4287000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4287000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1397400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1413500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.04
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1100000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.08
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2543000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2543000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,806000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,806000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1737000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,978000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,300000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,201000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,12000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,198000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-108000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1591000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,146000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,88000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-36000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-124000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,1000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1397400000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1413500000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1100000000.0
Boston Scientific Corp,BSX,Y6ZDD9FP4P8JSSJMW954,0000885725,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 17:20:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
